360° SearchNetwork Hot Spots Trends Time Series

Myocardial Infarction

Type: Keyphrase

Name: Myocardial Infarction

First reported May 20 2013 - Updated 8 hours ago - 2 reports

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)-- STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), announced today that the first ... [Published Pharmaceutical & Medical Packaging News - May 20 2013]

Entities: Stentys SA, Stent, Patient, Clinical trials, Heart Attack

First reported 9 hours ago - Updated 9 hours ago - 1 reports

The Softer Side of Bleeding ⁎ ⁎

Amin et al. (6) use the multicenter, national TRIUMPH (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status) registry design to explore the impact of dual oral antiplatelet therapy on a softer ... [Published Journal of the American College of Cardiology - 9 hours ago]

Entities: Hemoglobin, Myocardial Infarction, Blood Transfusion

First reported 15 hours ago - Updated 15 hours ago - 1 reports

Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status

Objectives The purpose of this study was to examine the incidence of nuisance bleeding after AMI and its impact on QOL.Background Prolonged dual antiplatelet therapy (DAPT) is recommended after acute myocardial infarction (AMI) to reduce ischemic events, ... [Published Journal of the American College of Cardiology - 15 hours ago]

Entities: Myocardial Infarction, Patient, Consortium, Hazard Ratio

First reported 17 hours ago - Updated 17 hours ago - 1 reports

Aspiration catheter gets cleared in Europe

The Export Advance aspiration catheter, a thrombus removal system, received CE mark and will be launched in Europe and other international markets.The Export Advance aspiration catheter includes a preloaded stylet to enhance deliverability and kink resistance, ... [Published Cardiovascular Business - 17 hours ago]

Entities: Catheter, Thrombus, Percutaneous Coronary Intervention, Myocardial Infarction, Stent

First reported 20 hours ago - Updated 20 hours ago - 1 reports

American Heart Association

Memorial Hospital Receives Award For Heart Attack Care

Memorial Hospital has received the American Heart Association’s Mission: Lifeline® Silver Receiving Quality Achievement Award. The award recognizes Memorial’s commitment and success in implementing an exceptional standard of care for heart attack pat ... [Published Chattanoogan - 20 hours ago]

Entities: Heart Attack, Patient, American Heart Association, Artery

First reported 23 hours ago - Updated 23 hours ago - 1 reports

Hospice

Health briefs 5/21/2013

Hendrick named as honors recipientHendrick Hospice Care has been named a recipient of the 2013 Hospice Honors, described by the hospital as a “prestigious award recognizing hospice agencies providing the best patient care as rated by the patient’s ca ... [Published Abilene Reporter - 23 hours ago]

Entities: Hospice, Heart Attack, Patient

First reported May 20 2013 - Updated 23 hours ago - 2 reports

iPhone

Study: New iPhone App Faster Than E-mail for Transmitting Heart Images

An iPhone application transmitted diagnostic heart images faster and more reliably than e-mailing photo images, according to a research study presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2013, ... [Published Healthcare Informatics Online - 23 hours ago]

Entities: iPhone, American Heart Association, Heart Attack, University of Virginia School of Medicine

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert L. Wilensky, MD, Professor of Medicine and Director of Interventional Cardiology Research at the University ... [Published Zecco - May 20 2013]

Entities: Cardiology, Stem Cell, Advisory Board, Myocardial Infarction, allogeneic

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Sewing up the definitive heart attack

Critical illness heart attack definitions are under scrutiny as medical advances redefine the condition, as Joan Riverson explains the main conditions covered under CI policies in the UK have been subject to standardised definitions, determined by the ... [Published Cover Magazine - May 20 2013]

Entities: Heart Attack, Artery, Myocardial Infarction

First reported May 19 2013 - Updated May 19 2013 - 1 reports

Digital Health For Dummies

A day doesnât go by when Iâm asked about digital health.What surprises me most about the perceptions around digital health is the misperceptions. From sophisticated marketers to to the average joe on the street, people just donât get it. And thatâs not ... [Published Forbes.com - May 19 2013]

Entities: Health Care, Blood Glucose, Glucose

First reported May 19 2013 - Updated May 19 2013 - 1 reports

Intensive-dose statin therapy reduces hospitalization rates in older Ontarians who have had a heart attack

Toronto - A new study by scientists at the Institute for Clinical Evaluative Sciences (ICES) and Sunnybrook Health Sciences Centre in Toronto shows that intensive-dose statin therapy is effective in reducing repeat hospitalization for acute coronary syndrome ... [Published Health Canal - May 19 2013]

Entities: Statins, Heart Attack, Patient

First reported May 19 2013 - Updated May 19 2013 - 1 reports

CellAegis Devices Announces Second Clinical Program to Use the Company's Noninvasive autoRIC Device for Chronic Remote Ischemic Conditioning CRIC...

CellAegis Devices Announces Second Clinical Program to Use the Company's Noninvasive autoRIC Device for Chronic Remote Ischemic Conditioning CRIC following Acute Myocardial Infarction AMIBy a News Reporter-Staff News Editor at Heart Disease Weekly CellAegis ... [Published Pharmacy Choice - May 19 2013]

Entities: Myocardial Infarction, Percutaneous Coronary Intervention, congestive heart failure

Quotes

"This study is a breakthrough for our research group after years of work. When we reduce the production of the enzyme in mice, the development of all the clinical symptoms of progeria is reduced or blocked. We have also studied cultured cells from children with progeria, and can see that when the enzyme is inhibited, the growth of the cells increases by the same mechanism as in mouse cells" says Martin Bergö, Professor at the Sahlgrenska Academy, University of Gothenburg, and research director at the Sahlgrenska Cancer Center

New breakthrough in progeria treatment [Published News-Medical.Net - 15 hours ago]

"In contrast, when patients who are in the hospital for a non-cardiac condition have a STEMI, the onset is not usually heralded by chest pain and, thus, health care providers may not suspect that a coronary artery has occluded. As a result, the time it takes for restoration of coronary blood flow for inpatients is much slower and more variable" Stouffer said

Inpatients Who Have STEMI Heart Attacks More Likely to Die Than Outpatients [Published Diagnostic & Invasive Cardiology - May 20 2013]

Stephen Epstein, MD, Chairman of Stemedica's Cardiology Division Scientific and Medical Advisory Board commented, "Dr. Wilensky's strong interest and expertise in both interventional cardiology and translational medicine, most notably with stem cells, parallels and strongly supports the direction we are taking with Stemedica."

Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Adv ... [Published Zecco - May 20 2013]

...Mehran. "We would like to congratulate Dr. Karel Koch from Amsterdam Medical Center for enrolling the first patient in this stuidy."

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial [Published Pharmaceutical & Medical Packaging News - May 20 2013]

More Content

sort by: Date \| Relevance
Older, sicker men with prostate cancer may bypa... [Published HealthImaging - 3 hours ago]
Clinical Factor 2012 [Published Sexual Development - 3 hours ago]
New Options for Hepatitis C, Osteoporosis. One ... [Published Consultant Live - 4 hours ago]
The Softer Side of Bleeding ⁎ ⁎ [Published Journal of the American College of Cardiology - 9 hours ago]
NeuroVive Pharmaceutical AB (NVP) - Pharmaceuti... [Published Live-PR.com - 9 hours ago]
Stimulating Myocardial Regeneration with Perios... [Published Elites TV - 11 hours ago]
Nuisance Bleeding With Prolonged Dual Antiplate... [Published Journal of the American College of Cardiology - 15 hours ago]
New breakthrough in progeria treatment [Published News-Medical.Net - 15 hours ago]
Aspiration catheter gets cleared in Europe [Published Cardiovascular Business - 17 hours ago]
Memorial Hospital Receives Award For Heart Atta... [Published Chattanoogan - 20 hours ago]
Health briefs 5/21/2013 [Published Abilene Reporter - 23 hours ago]
Angry outbursts are linked to increased risk of... [Published Washington Post - 23 hours ago]
Study: New iPhone App Faster Than E-mail for Tr... [Published Healthcare Informatics Online - 23 hours ago]
iPhone App Helps Diagnose Heart Attacks [Published P&T Community - May 20 2013]
Inpatients Who Have STEMI Heart Attacks More Li... [Published Diagnostic & Invasive Cardiology - May 20 2013]
Callous Indifference From Military Contractor i... [Published Ms Sparky - May 20 2013]
Noted Cardiologist Robert Wilensky to Join Stem... [Published Zecco - May 20 2013]
Sewing up the definitive heart attack [Published Cover Magazine - May 20 2013]
STENTYS Enrolls First Heart Attack Patient in P... [Published Pharmaceutical & Medical Packaging News - May 20 2013]
Market Trends Offer Opportunities for FPMI - An... [Published Nasdaq - May 20 2013]
Market Trends Offer Opportunities for FPMI Zacks [Published Yahoo! Finance - May 20 2013]
High LDL-C may not predict MI in CKD [Published Medical Observer - May 20 2013]
STENTYS Enrolls First Heart Attack Patient in P... [Published Zecco - May 20 2013]
Absorbable Stents Take Spotlight at EuroPCR [Published MedPage Today - May 20 2013]
Market Trends Offer Opportunities for FPMI Zack... [Published Yahoo! Finance - May 20 2013]
NeoStem expands IP coverage of cardiovascular a... [Published PharmaBiz - May 20 2013]
Sepsis code [Published Hospital Pharmacy Europe - May 20 2013]
South Korea Pharmaceutical Market Outlook 2013 [Published Individual.com - May 20 2013]
Lothians patients denied life-saving heart drug [Published The Scotsman - May 20 2013]
Medtronic Receives 'CE' Mark for 'Export Advanc... [Published OSIX News - May 20 2013]

Blogs

sort by: Date \| Relevance
A study contributes to the deceptive rebranding... [Published ScienceBlogs : Combined Feed - May 20 2013] That naturopathy is a veritable cornucopia of quackery mixed with the odd sensible, science-based suggestion here and there is not in doubt, at least not to supporters of science-based medicine (SBM). However, what naturopaths are very good at doing ...
Inhibiting ICMT as a Progeria Therapy [Published Fight Aging! - May 17 2013] Progress towards a therapy for the rare accelerated aging condition progeria continues. It remains unclear as to whether the mechanisms responsible for progeria exist in normal aging to a level that is in any way significant. Progeria is caused by ...
4 Healthcare Stock Stories For Thursday Investi... [Published Wall St. Cheat Sheet - May 16 2013] Johnson & Johnson ( NYSE:JNJ ): Closing price $87.45J&J’s Janssen Biotech announced Thursday that the FDA has cleared Simponi (golimumab) for the treatment of moderately to severely active ulcerative colitis in adult patients who have shown corticosteroid ...
4 Healthcare Stock Stories For Thursday Investi... [Published Wall St. Cheat Sheet - May 16 2013] Johnson & Johnson ( NYSE:JNJ ): Closing price $87.45 J&J’s Janssen Biotech announced Thursday that the FDA has cleared Simponi (golimumab) for the treatment of moderately to severely active ulcerative colitis in adult patients who have shown corticosteroid ...
The deceptive rebranding of aspects of science-... [Published Science-Based Medicine - May 13 2013] That naturopathy is a veritable cornucopia of quackery mixed with the odd sensible, science-based suggestion here and there is not in doubt, at least not to supporters of science-based medicine (SBM). However, what naturopaths are very good at doing ...

Press Releases

sort by: Date \| Relevance
BioLineRx Enters into “At-The-Market” Offering ... [Published Business Wire - May 17 2013]
Research and Markets: 2013 Disease and Therapy ... [Published Business Wire Health News - May 15 2013]
Elixir Medical Receives CE Mark Approval for th... [Published Business Wire - May 15 2013]
Arrhythmia Research Technology, Inc. Announces ... [Published Marketwire - Breaking News Releases - May 10 2013]
FirstMark's Clinical Study for Predicting Near-... [Published PR Newswire: Entertainment & Media - May 09 2013]